Drug discovery by targeting the protein–protein interactions involved in autophagy
Autophagy is a cellular process in which proteins and organelles are engulfed in autophagosomal vesicles and transported to the lysosome/vacuole for degradation. Protein–protein interactions (PPIs) play a crucial role at many stages of autophagy, which present formidable but attainable targets for a...
Gespeichert in:
Veröffentlicht in: | Acta pharmaceutica Sinica. B 2023-11, Vol.13 (11), p.4373-4390 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Autophagy is a cellular process in which proteins and organelles are engulfed in autophagosomal vesicles and transported to the lysosome/vacuole for degradation. Protein–protein interactions (PPIs) play a crucial role at many stages of autophagy, which present formidable but attainable targets for autophagy regulation. Moreover, selective regulation of PPIs tends to have a lower risk in causing undesired off-target effects in the context of a complicated biological network. Thus, small-molecule regulators, including peptides and peptidomimetics, targeting the critical PPIs involved in autophagy provide a new opportunity for innovative drug discovery. This article provides general background knowledge of the critical PPIs involved in autophagy and reviews a range of successful attempts on discovering regulators targeting those PPIs. Successful strategies and existing limitations in this field are also discussed.
Small-molecule regulators targeting the critical PPIs involved in autophagy provide a new opportunity for autophagy intervention and innovative drug discovery. [Display omitted] |
---|---|
ISSN: | 2211-3835 2211-3843 |
DOI: | 10.1016/j.apsb.2023.07.016 |